Clinical High Risk Syndrome of Psychosis
📧 Sign up to get email alerts when something new happens for Clinical High Risk Syndrome of Psychosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) [Phase 3]
Phase 3 trial evaluating sulforaphane to reduce risk of psychosis in individuals at clinical high risk.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) [Phase 3]
A Phase 3 clinical trial investigating sulforaphane to decrease risk of psychosis in individuals at clinical high risk is currently recruiti…